SCHEMBL8433396

SCHEMBL8433396

O=C(O)C1(O)C=CC=CC1.c1c[nH]nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18599190 0.80
SCHEMBL809925 0.80
Bicarbonate SCHEMBL5682507 0.70
Bicarbonate SCHEMBL1563325 0.70
SCHEMBL27493911 0.70
SCHEMBL466305 0.66
Carbamic Acid SCHEMBL1682079 0.66
Acetic Acid SCHEMBL9630666 0.66 FFAR3 (0.35)
SCHEMBL10348977 0.66
SCHEMBL4107307 0.66 GAA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863930-A ATHEROSCLEROSIS TREATMENT FORMED BY REACTION OF PYRIDONES WITH BIPHENYLMETHYL HALOGEN BAYER AKTIENGESELLSCHAFT (DE) 1999-01-26 US disclosed
CN-1040435-C Trisubstituted biphenyls BAYER AG (DE) 1998-10-28 CN disclosed
US-5596006-A ANTIHYPERTENSIVE, ANTIATHEROSCLEROTIC AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1997-01-21 US disclosed
CN-1089260-A Trisubstituted biphenyls BAYER AG (DE) 1994-07-13 CN disclosed